Viking Therapeutics, Inc. (VKTX)
Nasdaq: VKTX · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2014
Who runs Viking Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Lian Brian
President & CEO. First filing Apr 2015, latest Jul 29, 2026, 18 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
15 people on the record since 2015
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Lian Brian | President & CEO | Apr 2015 | Jul 29, 2026 | 6 · $14.0M |
| Zante Greg | Chief Financial Officer | Jan 2021 | Jul 29, 2026 | 6 · $2.8M |
| Mancini Marianna | Chief Operating Officer | Jan 2021 | Jul 29, 2026 | 6 · $2.7M |
| Chen Hubert C | Chief Medical Officer | Jun 2026 | Jun 3, 2026 | none |
| Aubuchon Neil William | Chief Commercial Officer | Jan 2026 | Mar 10, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kelly-Gemmell Dorothy Elizabeth | director | Aug 2026 | Aug 7, 2026 | none |
| Foehr Matthew W | director | Apr 2015 | Jan 5, 2026 | 1 · $600,000 |
| Macartney Lawson | director | Apr 2015 | Jan 5, 2026 | none |
| Rouan Sarah Kathryn | director | Jul 2019 | Jan 5, 2026 | none |
| Rowland Charles A Jr | director | Jul 2017 | Jan 5, 2026 | 1 · $2.1M |
| Singleton J Matthew | director | Apr 2015 | Jan 5, 2026 | none |
Earlier names on the record5, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.